Tools

Drug developers are facing the perfect storm. They are confronted with major patent expiries, increased payer scrutiny, changing priorities, shifting… »   

Achillion Pharmaceuticals Inc said the U.S. Food and Drug Administration allowed it to resume the development of one of… »   

A study by Belgian doctoral researcher Wouter De Haes (KU Leuven) and colleagues provides new evidence that metformin, the world’s… »   

The U.S. Food and Drug Administration said on Friday it has approved a new drug to treat acute bacterial skin… »   

U.S. health regulators on Friday approved Qiagen NV’s gene-testing kit to identify those colorectal cancer patients most likely to… »   

Merck & Co Inc and Endocyte Inc said they had stopped a late-stage trial of their experimental ovarian cancer… »   

Acorda Therapeutics Inc said the Food and Drug Administration rejected its nasal form of the current standard therapy for epilepsy… »   

German drugmaker Bayer AG is exploring the sale of its $10 billion plastics unit to focus on growing its health… »   

Actavis Plc said on Monday it has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive… »   

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may… »